On March 13, 2023, the board of directors of Amylyx Pharmaceuticals, Inc. appointed Karen Firestone to fill the vacancy on the Board as a Class I director, effective as of March 16, 2023 (the Effective Date), for an initial term expiring at the annual meeting of stockholders in 2025. Ms. Firestone has been appointed as a member of the Audit Committee and Nominating and Corporate Governance Committee.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.77 USD | +0.57% | +2.91% | -87.98% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-87.98% | 120M | |
+0.82% | 91.94B | |
-1.32% | 38.74B | |
-12.88% | 32.82B | |
+64.77% | 26.66B | |
-16.31% | 15.32B | |
-11.38% | 11.65B | |
+173.10% | 10.37B | |
-49.84% | 10.12B | |
+5.24% | 9.06B |
- Stock Market
- Equities
- AMLX Stock
- News Amylyx Pharmaceuticals, Inc.
- Amylyx Pharmaceuticals, Inc. Appoints Karen Firestone as Class I Director